INTRANASAL DELIVERY OF THE BISPHOSPHONATE ALENDRONATE IN THE RAT AND DOG

被引：12
|
作者：
SUTTON, SC [1 ]
ENGLE, K [1 ]
FIX, JA [1 ]
机构：
[1] INTERX RES CORP,MSDRL,LAWRENCE,KS 66047
来源：
PHARMACEUTICAL RESEARCH | 1993年 / 10卷 / 06期
关键词：
NASAL ABSORPTION; NASAL DRUG DELIVERY; BISPHOSPHONATE; RAT; DOG; ALENDRONATE;
D O I：
10.1023/A:1018981832261
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：924 / 926
页数：3
相关论文
共 50 条
  • [31] Intranasal delivery to the brain
    Henkin, Robert I.
    NATURE BIOTECHNOLOGY, 2011, 29 (06) : 480 - 480
  • [32] Intranasal drug delivery
    Hussain, AA
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) : 39 - 49
  • [33] Intranasal delivery of morphine
    Illum, L
    Watts, P
    Fisher, AN
    Hinchcliffe, M
    Norbury, H
    Jabbal-Gill, I
    Nankervis, R
    Davis, SS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01): : 391 - 400
  • [34] Intranasal delivery of nanoparticles
    Friedrich, Ralf P.
    Cicha, Iwona
    Tietze, Rainer
    Unterweger, Harald
    Lyer, Stefan
    Janko, Christina
    Alexiou, Christoph
    NANOMEDICINE, 2022, 17 (02) : 71 - 76
  • [35] A histopathologicai investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible
    Kaynak, D
    Meffert, R
    Bostanci, H
    Günhan, Ö
    Özkaya, ÖG
    JOURNAL OF PERIODONTOLOGY, 2003, 74 (09) : 1348 - 1354
  • [36] Novel biomaterials for bisphosphonate delivery
    Josse, S
    Faucheux, C
    Soueldan, A
    Grimandi, G
    Massiot, D
    Alonso, B
    Janvier, P
    Laïb, S
    Pilet, P
    Gauthier, O
    Daculsi, G
    Guicheux, J
    Bujoli, B
    Bouler, JM
    BIOMATERIALS, 2005, 26 (14) : 2073 - 2080
  • [37] ORAL ALENDRONATE AND INTRANASAL CALCITONIN IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    ADAMI, S
    LOMBARDI, A
    ORTOLANI, S
    PASSERI, M
    CAPIZZI, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S254 - S254
  • [38] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    Palmisano, J
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S197 - S197
  • [39] Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
    Downs, RW
    Bell, NH
    Ettinger, MP
    Walsh, BW
    Favus, MJ
    Mako, B
    Wang, LX
    Smith, ME
    Gormley, GJ
    Melton, ME
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05): : 1783 - 1788
  • [40] Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis
    M. Yilmaz
    H. Taninmis
    E. Kara
    A. Ozagari
    A. Unsal
    Osteoporosis International, 2012, 23 : 2059 - 2062
12345